This is the P2 Tox study out of Australia. It was originally a 52 (?) week study that has been extended at the request of the subjects and their care givers. Efficacy was a secondary end point of the trial which had no placebo.
What was shown today is the title of the presentation. The data of the 19 subjects still in the trial is what will be presented.
News 
Market Data 
Discover 
